Fr. 52.50

Combating the Menace of Microbial Resistance - Novel Antimicrobial Drugs of Natural and Synthetic Origin

English, German · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

Research and development for novel antimicrobial drugs having different mode of action has become an urgent task for scientific community because of escalating resistance towards currently used antibiotics in clinical practice. The menace of microbial resistance may be dealt with novel antimicrobial drugs of natural and synthetic origin as per the recent most literature. This communication is a coherent endeavor to summarize the potent antimicrobial profiles of various heterocyclic derivatives for drug design and development of promising and advanced antimicrobial drugs in search of providing better treatment to the patients globally.

About the author










El Dr. Rajeev Kharb trabaja actualmente como profesor asociado en el Instituto de Farmacia Amity, Universidad Amity de Uttar Pradesh, Noida, India. Tiene una experiencia docente y de investigación de 16,5 años. El autor ha publicado 40 artículos de revisión y de investigación y ha escrito 4 libros. Su área de investigación incluye la síntesis de compuestos heterocíclicos.

Product details

Authors Surya Prakas Gautam, Surya Prakash Gautam, Paramjee Kaur, Paramjeet Kaur, Rajee Kharb, Rajeev Kharb
Publisher LAP Lambert Academic Publishing
 
Languages English, German
Product format Paperback / Softback
Released 31.03.2015
 
EAN 9783659405402
ISBN 978-3-659-40540-2
No. of pages 76
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.